In this study, we demonstrated that AFP quantification from cfDNA and CTCs provides a more accurate and clinically informative assessment compared to conventional serum AFP levels for the diagnosis and prognosis of HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.